Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension.
作者信息
Guo Yangkun, Ma Xiong, Nie Yongzhan, Kostallari Enis, Gao Jinhang
机构信息
Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
Division of Gastroenterology and Hepatology, National Healthy Commission (NHC) Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, Shanghai, China.
出版信息
Front Immunol. 2023 Mar 9;14:1174562. doi: 10.3389/fimmu.2023.1174562. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension.社论：肝硬化和门静脉高压症背后的肝脏免疫反应
Front Immunol. 2023 Mar 9;14:1174562. doi: 10.3389/fimmu.2023.1174562. eCollection 2023.
2
Editorial: Community series in hepatic immune response underlying liver cirrhosis and portal hypertension, volume II.社论：肝硬化和门静脉高压症潜在肝脏免疫反应的社区系列，第二卷。
Front Immunol. 2023 Oct 11;14:1305666. doi: 10.3389/fimmu.2023.1305666. eCollection 2023.
3
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.肠-肝轴、肝硬化和门静脉高压：先有鸡还是先有蛋。
Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26.
4
Gut-liver axis signaling in portal hypertension.门脉高压症中的肠道-肝脏轴信号。
World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897.
5
Revisiting the gut-liver axis: gut lymphatic system in liver cirrhosis and portal hypertension.重新审视肠-肝轴：肝硬化和门静脉高压症中的肠道淋巴系统。
Am J Physiol Gastrointest Liver Physiol. 2022 May 1;322(5):G473-G479. doi: 10.1152/ajpgi.00271.2021. Epub 2022 Feb 23.
6
Liver surgery in cirrhosis and portal hypertension.肝硬化和门静脉高压症的肝脏手术
World J Gastroenterol. 2016 Mar 7;22(9):2725-35. doi: 10.3748/wjg.v22.i9.2725.
7
Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.丙型肝炎病毒相关肝硬化门静脉高压的病理生理学。门静脉压力梯度评估在聚乙二醇干扰素治疗患者中的潜在作用。
Dig Liver Dis. 2005 Nov;37(11):886-93. doi: 10.1016/j.dld.2005.04.029. Epub 2005 Sep 19.
8
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.全PPAR激动剂拉尼非诺能改善实验性晚期慢性肝病中的门静脉高压和肝纤维化。
J Hepatol. 2021 May;74(5):1188-1199. doi: 10.1016/j.jhep.2020.11.045. Epub 2020 Dec 2.
9
Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.治疗慢性肝脏疾病相关门静脉高压和肝纤维化的新疗法。
Pharmacol Ther. 2020 Nov;215:107626. doi: 10.1016/j.pharmthera.2020.107626. Epub 2020 Jul 11.
10
Potential mechanisms linking gut microbiota and portal hypertension.肠道微生物群与门静脉高压相关的潜在机制。
Liver Int. 2019 Apr;39(4):598-609. doi: 10.1111/liv.13986. Epub 2018 Nov 9.
本文引用的文献
1
Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host.中性粒细胞在宿主防御、愈合及超敏反应中的作用：动态宿主内的动态细胞
J Allergy Clin Immunol. 2023 Mar;151(3):634-655. doi: 10.1016/j.jaci.2022.12.004. Epub 2023 Jan 14.
2
The evolving role of liver sinusoidal endothelial cells in liver health and disease.肝窦内皮细胞在肝脏健康和疾病中的作用演变。
Hepatology. 2023 Aug 1;78(2):649-669. doi: 10.1097/HEP.0000000000000207. Epub 2023 Jan 3.
3
Alcohol-Associated Hepatitis.酒精性肝炎
N Engl J Med. 2022 Dec 29;387(26):2436-2448. doi: 10.1056/NEJMra2207599.
4
Macrophages in health and disease.巨噬细胞在健康与疾病中的作用
Cell. 2022 Nov 10;185(23):4259-4279. doi: 10.1016/j.cell.2022.10.007.
5
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice.非酒精性脂肪性肝病中的门静脉高压：从发病机制到临床实践
J Clin Transl Hepatol. 2022 Oct 28;10(5):979-985. doi: 10.14218/JCTH.2021.00593. Epub 2022 Jul 19.
6
Intestinal homeostasis in autoimmune liver diseases.自身免疫性肝病中的肠道稳态。
Chin Med J (Engl). 2022 Jul 20;135(14):1642-1652. doi: 10.1097/CM9.0000000000002291.
7
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.免疫机制将代谢损伤与脂肪肝疾病中的炎症和纤维化联系起来——细胞通讯回路的新见解。
J Hepatol. 2022 Oct;77(4):1136-1160. doi: 10.1016/j.jhep.2022.06.012. Epub 2022 Jun 22.
8
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.脾切除术可改善肝硬化和非肝硬化门静脉高压动物模型的门静脉压力和贫血。
Adv Med Sci. 2022 Mar;67(1):154-162. doi: 10.1016/j.advms.2022.02.005. Epub 2022 Mar 8.
9
Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis.细胞程序性坏死在酒精性肝病和肝发病机制中的作用。
Cell Prolif. 2022 Mar;55(3):e13193. doi: 10.1111/cpr.13193. Epub 2022 Jan 26.
10
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches.空间蛋白质组学揭示了独特且进化上保守的肝巨噬细胞生态位。
Cell. 2022 Jan 20;185(2):379-396.e38. doi: 10.1016/j.cell.2021.12.018. Epub 2022 Jan 11.
Zotero 插件